BrokerLens

Remus Pharmaceuticals Limited IPO (REMUS)

Status
Listed
Security type
SME
Price band
Rs.1150 TO Rs.1229
Final issue price
Rs 1229
Issue size
Not disclosed
Bidding opens
17 May 2023
Bidding closes
19 May 2023
Listing date
29 May 2023

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Remus Pharmaceuticals Limited IPO?

The Remus Pharmaceuticals Limited IPO price band is Rs.1150 TO Rs.1229 per share.

When does the Remus Pharmaceuticals Limited IPO open and close?

Bidding opens 17 May 2023 and closes 19 May 2023.

Is the Remus Pharmaceuticals Limited IPO a mainboard or SME issue?

Remus Pharmaceuticals Limited is an SME IPO, listing on NSE Emerge.

When did the Remus Pharmaceuticals Limited IPO list?

Remus Pharmaceuticals Limited listed on 29 May 2023.

Does this page show the grey market premium (GMP) for Remus Pharmaceuticals Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Remus Pharmaceuticals Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.